Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > A Promising Target to Treat… >
A Promising Target to Treat Asthma

Published: July 24, 2013.
By University of Iowa
http://www.uiowa.edu

An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers say.

Asthma affects billions of people worldwide. In the United States, 8.5 percent of the population has asthma, which causes 3,000 deaths and more than $56 billion annually in medical and lost work costs, according to the federal Centers for Disease Control and Prevention. Despite its toll on health and productivity, treatment options remain confined to steroids, which have harmful, even life-threatening, side effects for those with severe cases.

Current treatments don't work well, noted Mark Anderson, professor and chair in internal medicine at the UI and a co-corresponding author on the paper, published July 24 in the journal Science Translational Medicine.

"It's a kind of an epidemic without a clear, therapeutic option," Anderson says. "The take-home message is that inhibiting CaMKII appears to be an effective anti-oxidant strategy for treating allergic asthma."

Anderson and co-corresponding author Isabella Grumbach knew from previous work that the CaMKII enzyme played a role in the oxidation of heart muscle cells, which can lead to heart disease and heart attacks. The scientists surmised the same enzyme may affect oxidation in the respiratory system as well.

The team first tested the enzyme in airway muscle cells, but to little effect. They then tried to block the enzyme in the airway lining (epithelial) cells. They noticed that mice with the blocked enzyme had less oxidized CaMKII, no airway muscle constriction and no asthma symptoms. Similarly, mice without the blocked enzyme showed high "oxidative stress," meaning lots of oxidized enzymes in the epithelial cells, a constricted airway and asthma symptoms.

"[The study] suggests that these airway lining cells are really important for asthma, and they're important because of the oxidative properties of CaMKII," says Anderson, whose primary appointment is in the Carver College of Medicine. "This is completely new and could meet a hunger for new asthma treatments. Here may be a new pathway to treat asthma."

"Ten years ago, not much was known about what CaMKII does outside of nerve cells and muscle cells in the heart," says Grumbach, associate professor in internal medicine at the UI. "My lab has worked on investigating its function mainly in blood vessels with the long-term goal to use blockers of CaMKII to treat common diseases. We are constantly finding that CaMKII is interesting and important."

The researchers also took tissue samples from the airways of patients with asthma. True to their hypothesis, they found more oxidized enzymes in those patients than in healthy individuals. Taking a step further, the team found that mild asthma patients who inhaled an allergen had a spike in oxidized CaMKII in the epithelial cells just a day later.

"We have this very compelling association," Anderson says, adding that more studies in patients are needed to validate the approach.

The researchers also plan to investigate inhaled drugs that could block the oxidation of theCaMKII enzyme, for treating heart disease and asthma. Anderson has a patent and is involved in a company, Allosteros Therapeutics, which is seeking to develop such a drug.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Remodeling 
3/23/11 
Protein Associated with Allergic Response Causes Airway Changes in Asthma Patients
By American Thoracic Society
Changes that occur in the airways of asthma patients are in part caused by the naturally occurring protein interleukin-13 (IL-13) which stimulates invasion of airway cells called fibroblasts, according …
Cells 
4/11/13 
BUSM Researchers Identify Novel Approach to Study COPD And Treatment Efficacy
By Boston University Medical Center
(Boston) – Researchers from Boston University School of Medicine (BUSM) have pinpointed a genetic signature for chronic obstructive pulmonary disease (COPD) from airway cells harvested utilizing a minimally invasive …
Airway 
5/16/10 
Estrogen May Reduce Airway Constriction in Women Patients with Asthma
By American Thoracic Society
ATS 2010, NEW ORLEANS— Female sex hormones may work with beta-agonists in reducing airway constriction, according to new bench research from the Mayo Clinic. The findings will be …
Inflammation 
2/27/13 
Scientists Discover Molecule That Does Double Duty in Stopping Asthma Attacks
By Brigham and Women's Hospital
BOSTON, MA—Scientists from Brigham and Women's Hospital are on the brink of the next treatment advancement that may spell relief for the nearly nineteen million adults and seven million …
Patients 
8/8/11 
Pitt Team Finds Molecular Pathway That Leads to Inflammation in Asthma
By University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, Aug. 8 – Researchers at the University of Pittsburgh School of Medicine have identified a molecular pathway that helps explain how an enzyme elevated in asthma patients can …
Patients 
10/25/13 
Hope of New Treatment for Severe Asthma Patients
By RIKEN
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the …
Testing 
4/2/14 
'3D' Test Could Reduce Reliance on Animals for Testing Asthma And Allergy Medications
By American Chemical Society
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging. In …
Cells 
1/3/14 
★★★ 
Odor Receptors Discovered in Lungs
By Washington University in St. Louis
Your nose is not the only organ in your body that can sense cigarette smoke wafting through the air. Scientists at Washington University in St. Louis and the University …
Duke 
1/18/11 
Findings on Pollution Damage to Human Airways Could Yield New Therapies
By Duke University Medical Center
DURHAM, N.C. – Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.